V8 Peptides — Engineered Performance
Research Library
What Is Pinealon? The EDR Tripeptide and Its Research
PinealonEDRBackground

What Is Pinealon? The EDR Tripeptide and Its Research

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer: Pinealon is a market name for the tripeptide Glu-Asp-Arg (EDR, a little over 400 Da) studied by Khavinson and colleagues. Published work is mostly cell cultures plus one rat model, largely from one network of laboratories, so it is early evidence. V8 does not sell pinealon; this page is research background only.

A tripeptide sold under a product name

Pinealon is the name used in the research-peptide market for a tripeptide made of glutamate, aspartate and arginine, written Glu-Asp-Arg or EDR. It comes from the same St. Petersburg group of researchers, led by Vladimir Khavinson, that studied a family of very short peptides they call peptide bioregulators. Searches for the name have grown alongside interest in related short peptides, and the same group's work on a different tripeptide is covered in our Cartalax guide.

This page explains what the published laboratory work reports, how far that evidence goes, and what to verify on a certificate before buying any such reagent. It is background for laboratory research use only. V8 Peptides does not sell pinealon, and nothing here describes an effect or use in people or animals.

What the molecule is

EDR has three amino acids. Two of them, glutamate and aspartate, carry acidic side chains and arginine carries a basic one, so the molecule is highly polar. Its mass is a little over 400 daltons, which is far smaller than the 1,000 to 4,000 dalton peptides most buyers see, such as those in the Selank and Semax guides.

A molecule this small has few distinguishing analytical features. It has no long chain to produce a rich fragmentation pattern, and it elutes early on a standard reversed-phase gradient. For that reason, a label that only says the product name does not tell you what is in the vial. The sequence and a measured mass are what identify it.

Side-by-side comparison

ItemWhat is reportedSource
SequenceGlu-Asp-Arg (EDR), a little over 400 DaCompound definition
Oxidative stress, cellsLess reactive oxygen species and necrotic death in cerebellar granule cells, neutrophils and PC12 cellsKhavinson 2011
Simple in vitro systemsLower share of dead cells in a neuronal population; no direct antioxidant activity in the test usedKozina 2008
Rat modelFewer reactive oxygen species and necrotic cells in offspring neurons in one hyperhomocysteinemia designArutjunyan 2012
Proposed mechanismEntry into the nucleus and interaction with DNA or histonesKhavinson 2020; Ilina 2022
DNA interaction, test tubePartial entry into the major groove; promoted by magnesiumSilanteva 2019
Independent replicationLimited; mostly one network of laboratoriesSee text

What the cell-culture papers report

The 2008 paper by Kozina and colleagues examined short regulatory peptides, including pinealon, in simple in vitro systems. They reported that the peptides did not show direct antioxidant activity in the test used, yet changed lipid peroxidation of lipoproteins through structural modification, raised the stability of red blood cell membranes against osmotic stress, and lowered the share of dead cells in a neuronal population.

In 2011, Khavinson and colleagues reported that pinealon limited accumulation of reactive oxygen species in cerebellar granule cells, neutrophils and PC12 cells under induced oxidative stress, and lowered necrotic cell death measured by propidium iodide. The protective readout was accompanied by a delayed time course of ERK 1/2 activation and changes in the cell cycle. The authors argued that the cell-cycle effect continued at concentrations higher than those needed for the antioxidant readout, and concluded that the peptide might interact with the cell genome.

All of these are cell-culture measurements under defined conditions. They describe changes in markers and cell survival in a dish, and cannot be read as effects in an organism.

What the animal paper reports

The 2012 paper by Arutjunyan and colleagues used rats in which a high-methionine diet during pregnancy produced elevated homocysteine. The authors reported that giving pinealon to the pregnant animals was followed by better results in offspring tests of spatial orientation and learning, and that cerebellar neurons isolated from the offspring accumulated fewer reactive oxygen species and showed fewer necrotic cells.

This is a single model, a single group and a specific condition. It is useful as a description of what was measured and how, and it should not be generalized to other species, routes or settings. The study design and the route used are detailed in the paper itself, and this page does not recommend any use.

The proposed mechanism

The group proposes that very short peptides can enter cells and reach the nucleus, where they interact with DNA or with histone proteins and change which genes are read. A 2020 review by Khavinson and colleagues collects reported changes in signaling through the MAPK/ERK pathway and in the expression of proteins in apoptosis and antioxidant pathways. A 2022 review by Ilina and colleagues places the idea in the wider area of epigenetic regulation by ultrashort peptides.

A physical chemistry paper from 2019 (Silanteva and colleagues) used spectroscopy, NMR, viscosimetry and molecular dynamics to examine EDR and DNA together. It reported that EDR can partly enter the major groove of DNA and that magnesium ions promote the interaction by screening the negative charge of the DNA phosphate backbone. That is a test-tube and simulation result, not a demonstration of binding at a specific gene in a living cell.

A careful reader keeps the layers apart: modeling shows what is possible, expression assays show that levels moved, and neither alone proves the mechanism. A claim that a three-residue peptide crosses membranes and acts on DNA is unusual and needs testing by independent laboratories.

How strong is the evidence?

It is early and narrow. Most of the papers come from one network of laboratories, several appear in regional journals or in Russian, and the models are limited to a few cell types and one rodent design. The physical chemistry paper comes from a separate group, which is a point in its favor.

None of that makes the work uninteresting. It means a study design should regard the reports as hypotheses to test, include controls, and state the model and readout clearly rather than quote a headline from a product page.

What a certificate should show for a pinealon reagent

For a tripeptide, identity matters most. Look for the sequence Glu-Asp-Arg, a measured mass beside the expected value, and a lot identifier and date. For background on reading these documents, see understanding HPLC purity, HPLC vs. mass spectrometry and how to read a COA.

Ask how HPLC purity was measured. A gradient that sends a very polar peptide through at the solvent front gives a less informative figure than a method tuned for polar peptides. Salt and water content also make up a larger share of the weight of a small peptide, which matters when a laboratory prepares a stock solution by weight.

For cell work, an endotoxin result and a sterility statement matter as much as purity. More buyer-side guidance is in choosing a peptide supplier and red flags when buying research peptides.

Handling and record keeping

Keep lyophilized peptide cold, dry and protected from light, and write the opening date on the vial. Short hydrophilic peptides can take up moisture quickly once a vial is open, so plan aliquots before opening. General guidance is in how long reconstituted peptides last and what a normal vial looks like. For concentration arithmetic use the reconstitution calculator.

In the notebook, record the compound name, sequence, lot, supplier, certificate date and storage conditions, so that a later reader can tie any result to a defined reagent. The certificates of analysis page shows what V8 publishes for the products it sells.

Certificate checklist for a short peptide

CheckWhat to look forWhy it matters
SequenceGlu-Asp-Arg named on the documentProduct names are not identifiers
Measured massValue printed beside the expected massSeparates it from similar short peptides
HPLC methodGradient and column describedPolar peptides can elute at the solvent front
Lot and dateBoth printed and matching the vialTies results to one defined reagent
Endotoxin, sterilityReported when used in cell workEndotoxin alone can trigger cell responses

Frequently asked questions

What is pinealon?

A market name for the tripeptide Glu-Asp-Arg (EDR), studied by Khavinson and colleagues as one of their short peptide bioregulators.

How big is the molecule?

A little over 400 daltons, which is very small and limits how much an analytical method can show about it.

What kind of studies exist?

Cell cultures, simple in vitro systems, one rat model, reviews and a physical chemistry study of its interaction with DNA.

Does the research show effects in people?

This guide makes no such claim. It covers laboratory research and is not evidence of any effect in people or animals.

Is pinealon the same as Cartalax or epitalon?

No. Cartalax is the tripeptide Ala-Glu-Asp and epitalon is the four-residue Ala-Glu-Asp-Gly. They have different sequences and masses.

Why does HPLC need care for a tripeptide?

Very polar short peptides can elute near the solvent front, so the method used affects how a purity figure should be read.

How can I check I have EDR and not another peptide?

Read the sequence and the measured mass on the certificate and compare them with the expected value.

Is the evidence independent?

Mostly not. Most papers come from one network of laboratories, with the DNA-interaction chemistry from a separate group.

Does V8 sell pinealon?

No. This page is research background and is not a product listing.

What should I record for each vial of any research peptide?

The exact compound name, sequence, lot identifier, certificate date, supplier, storage conditions and the date the vial was opened.

Does this article describe a use in people?

No. It summarizes published laboratory research and analytical practice, for laboratory research use only.

References

  1. Khavinson V, Ribakova Y, Kulebiakin K, Vladychenskaya E, Kozina L, Arutjunyan A, Boldyrev A. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Res. 2011;14(5):535-541. doi:10.1089/rej.2011.1172. PMID: 21978084.
  2. Arutjunyan A, Kozina L, Stvolinskiy S, Bulygina Y, Mashkina A, Khavinson V. Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. Int J Clin Exp Med. 2012;5(2):179-185. PMID: 22567179.
  3. Kozina LS, Arutiunian AV, Stvolinskii SL, Khavinson VKh. Biological activity of regulatory peptides in model experiments in vitro. Adv Gerontol. 2008;21(1):68-73. PMID: 18546826.
  4. Khavinson V, Linkova N, Kozhevnikova E, Trofimova S. EDR peptide: possible mechanism of gene expression and protein synthesis regulation. Molecules. 2020;26(1):159. doi:10.3390/molecules26010159. PMID: 33396470.
  5. Silanteva IA, Komolkin AV, Morozova EA, Vorontsov-Velyaminov PN, Kasyanenko NA. Role of mono- and divalent ions in peptide Glu-Asp-Arg-DNA interaction. J Phys Chem B. 2019;123(9):1896-1902. doi:10.1021/acs.jpcb.8b10359. PMID: 30762356.
  6. Ilina A, Khavinson V, Linkova N, Petukhov M. Neuroepigenetic mechanisms of action of ultrashort peptides. Int J Mol Sci. 2022;23(8). PMID: 35457077.

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.